← All Ultralife CORP filings

Ultralife CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
ULBI
Ultralife CORP
DEF: Ultralife Corporation 2026 Annual Meeting Proxy Statement
Ultralife Corporation announces its 2026 Annual Meeting of Stockholders, scheduled for July 22, 2026, to elect directors, ratify auditors, and vote on executive compensation.
NASDAQ
ULBI
Ultralife CORP
DEFA14A: Ultralife Corporation Files Definitive Additional Proxy Materials with SEC
Ultralife Corporation has filed definitive additional proxy materials (DEFA14A) with the U.S. Securities and Exchange Commission.
NASDAQ
ULBI
Ultralife CORP
DEF: Ultralife Corporation Schedules 2025 Annual Meeting, Details Executive Compensation and Governance Updates
Ultralife Corporation has announced its 2025 Annual Meeting of Stockholders to be held on July 16, 2025, where shareholders will vote on director elections and auditor ratification, alongside disclosures on executive compensation and corporate governance.
NASDAQ
ULBI
Ultralife CORP
DEFA14A: Ultralife Corporation Files Definitive Proxy Statement
Ultralife Corporation has filed a definitive proxy statement with the SEC, signaling upcoming shareholder actions.
NASDAQ
ULBI
Ultralife CORP
DEF 14A: Ultralife Corporation Seeks Stockholder Approval for New Long-Term Incentive Plan
Ultralife Corporation is asking stockholders to approve the Ultralife Corporation 2024 Long-Term Incentive Plan (New LTIP) at the upcoming annual meeting on July 16, 2024.